Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)

Critical Care Medicine

Volumn 37, Issue 2, 2009, Pages 410-416

  Póvoa, Pedro R ^a   Carneiro, António H ^b   Ribeiro, Orquídea S ^c   Pereira, Altamiro C ^c  

^a HOSPITAL DE SÃO FRANCISCO XAVIER   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Catecholamines; Community acquired sepsis; Septic shock; Survival; Vasoactive agents; Vasopressors

Indexed keywords

DOPAMINE; NORADRENALIN;

ADULT; AGED; ARTICLE; DEATH; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SEPTIC SHOCK; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DOPAMINE; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NOREPINEPHRINE; PORTUGAL; PROPORTIONAL HAZARDS MODELS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 67650401450     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181958b1c     Document Type: Article

References (25)

1. Vincent JL, Sakr Y, Sprung CL, et al: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34: 344-353
2. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
3. Beale RJ, Hollenberg SM, Vincent JL, et al: Vasopressor and inotropic support in septic shock: An evidence-based review. Crit Care Med 2004; 32:S455-S465
4. Bracco D: Pharmacologic support of the failing circulation: Practice, education, evidence, and future directions. Crit Care Med 2006; 34:890-892
5. Lieverse AG, Lefrandt JD, Girbes AR, et al: The effects of different doses of dopamine and domperidone on increases of plasma norepinephrine induced by cold pressor test in normal man. Hypertens Res 1995; 18(Suppl 1):S221-S224
6. Sladen RN: Inotropic agents. In: 1994 Yearbook of Intensive Care and Emergency Medicine. Vincent JL (ed). Berlin, Springer, 1994; pp 165-178
7. Bailey JM: Dopamine: One size does not fit all. Anesthesiology 2000; 92:303-305
8. Hollenberg SM, Ahrens TS, Annane D, et al: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004; 32:1928-1948
9. Mullner M, Urbanek B, Havel C, et al: Vaso-pressors for shock. Cochrane Database Syst Rev 2004: CD003709
10. Sakr Y, Reinhart K, Vincent JL, et al: Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Crit Care Med 2006; 34:589-597
11. Russell JA, Walley KR, Singer J, et al: Vaso-pressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
12. Annane D, Vignon P, Renault A, et al: Nor-epinephrine plus dobutamine versus epi-nephrine alone for management of septic shock: A randomised trial. Lancet 2007; 370: 676-684
13. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005; 365:63-78
14. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
15. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections. In: APIC Infection Control and Applied Epidemiology: Principles and Practice. Olmsted RN (ed). St. Louis, Mosby, 1996; pp A1-A20
16. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874
17. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multi-center study. JAMA 1993; 270:2957-2963
18. Vincent JL, de Mendonca A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26:1793-1800
19. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
20. De Miguel-Yanes JM, Andueza-Lillo JA, Gonzalez-Ramallo VJ, et al: Failure to implement evidence-based clinical guidelines for sepsis at the ED. Am J Emerg Med 2006; 24:553-559
21. Nguyen HB, Rivers EP, Knoblich BP, et al: Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32:1637-1642
22. Trzeciak S, Dellinger RP, Abate NL, et al: Translating research to clinical practice: A 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 2006; 129: 225-232
23. Gao F, Melody T, Daniels DF, et al: The impact of compliance with 6-hour and 24hour sepsis bundles on hospital mortality in patients with severe sepsis: A prospective observational study. Crit Care 2005; 9:R764 -R770
24. Kortgen A, Niederprum P, Bauer M: Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med 2006; 34:943-949
25. Cardoso T, Carneiro AH, Ribeiro O, et al: The Portuguese network data: Compliance with the Surviving Sepsis Campaign bundles. Abstr. Intensive Care Med 2006; 32:S23